Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyridones as potential antitumor agents.

D R Hwang, J S Driscoll

    Journal of Pharmaceutical Sciences
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Researchers explored 2-pyridone derivatives for anti-cancer activity against murine P-388 lymphocytic leukemia. Key structural features, including oxygen functional groups and specific isomeric arrangements, were identified as crucial for potent anti-leukemia effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds.

    Biochemical pharmacology·2010
    Same author

    Prediction of pathology and survival by FDG PET in gliomas.

    Journal of neuro-oncology·2003
    Same author

    Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2001
    Same author

    (-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors.

    Nuclear medicine and biology·2000
    Same author

    In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000
    Same author

    Positron emission tomography study of pindolol occupancy of 5-HT(1A) receptors in humans: preliminary analyses.

    Nuclear medicine and biology·2000

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Oncology

    Background:

    • Murine P-388 lymphocytic leukemia is a standard model for evaluating anti-cancer drug efficacy.
    • The 2-pyridone scaffold is a core structure in various biologically active molecules.
    • Initial findings indicated reproducible anti-leukemia activity for 3-acetoxy-2-pyridone.

    Purpose of the Study:

    • To synthesize and evaluate novel 2-pyridone derivatives.
    • To identify key structural features responsible for anti-leukemia activity against P-388 lymphocytic leukemia.
    • To optimize the 2-pyridone structure for enhanced anti-cancer potential.

    Main Methods:

    • Synthesis of a series of 32 2-pyridone derivatives.
    • In vitro evaluation of synthesized compounds against murine P-388 lymphocytic leukemia.

    Related Experiment Videos

  • Structure-activity relationship (SAR) analysis to determine critical functional groups and isomeric arrangements.

    • Main Results:

    • Ten out of 32 synthesized 2-pyridone derivatives exhibited significant anti-leukemia activity.
    • The presence of at least two oxygen-containing functional groups was essential for activity.
    • The 2,3-isomeric arrangement of functional groups on the pyridone ring was found to be optimal.
    • Carbamate or acyloxy groups at the 3-position of the 2-pyridone core yielded the most potent compounds.

    Conclusions:

    • The 2-pyridone scaffold can be effectively modified to generate potent anti-leukemia agents.
    • Specific structural requirements, including oxygenation patterns and 2,3-isomerism, are critical for P-388 lymphocytic leukemia inhibition.
    • Further development of these 2-pyridone derivatives holds promise for novel cancer therapeutics.